A Study of CS5001 in Patients With Advanced Solid Tumors and Lymphomas
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Rituximab
Related studies linked through entity extraction aliases.
Loncastuximab Tesirine in Combination With DA-EPOCH-R in Patients With Previously Untreated Aggressive B-cell Lymphoid Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Treatment of Relapsed or Refractory Diffuse Large B Cell Lymphoma With Ociperlimab (BGB-A1217) in Combination With Tislelizumab (BGB-A317) or Rituximab
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of ATG-010 in Combination With Lenalidomide and Rituximab (R2) in Adults With DLBCL and iNHL
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Pembrolizumab in Combination With R-ICE Chemotherapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Rituximab Plus Venetoclax in Combination With Zandelisib in Subjects With CLL
- Status
- WITHDRAWN
- Phase
- PHASE2
Minimizing Glucocorticoid Administration in Patients With Proliferative Lupus Nephritis
- Status
- RECRUITING
- Phase
- PHASE4
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab As Monotherapy or Combined With Standard of Care Therapies in Adult Participants in China With B-Cell Non-Hodgkin Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Phase II Study of Zanubrutinib, Lenalidomide Plus R-CHOP as the First-line Treatment for Diffused Large B-cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
A Study Evaluating Efficacy and Safety of Mosunetuzumab in Combination With Polatuzumab Vedotin Compared to Rituximab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Biologics in Refractory Vasculitis: A Trial of Biologic Therapy for Refractory Primary Non-ANCA Associated Vasculitis
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Loncastuximab Tesirine and Rituximab (Lonca-R) in Previously Untreated Unfit/Frail Participants With Diffuse Large B-cell Lymphoma (DLBCL)
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma
- Status
- RECRUITING
- Phase
- PHASE3
Safety and Efficacy of Intrathecal Rituximab in Patients With Multiple Sclerosis
- Status
- UNKNOWN
- Phase
- PHASE1
IBI376 Plus Rituximab in Patients With Untreated Indolent Lymphoma.
- Status
- UNKNOWN
- Phase
- PHASE2
ACALA-R In Predominantly Demyelinating IgM Mediated Neuropathy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Autologous Stem Cell Transplantation: International Lupus Trial
- Status
- WITHDRAWN
- Phase
- PHASE2/PHASE3
Reappraisal of the Therapies of Refractory Autoimmune Hemolytic Anemia in Systemic Lupus Erythematosus
- Status
- UNKNOWN
- Phase
- PHASE3
Second-line Treatment of Primary Autoimmune Hemolytic Anemia
- Status
- RECRUITING
- Phase
- PHASE3